Advertisement
U.S. markets open in 2 hours 59 minutes

Protalix BioTherapeutics, Inc. (PLX)

NYSE American - NYSE American Delayed Price. Currency in USD
1.2700-0.0600 (-4.51%)
At close: 04:00PM EDT
1.2700 0.00 (0.00%)
Pre-Market: 04:34AM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 3/19/2024
Current
12/31/20239/30/20236/30/20233/31/202312/31/2022
Market Cap (intraday)
92.78M129.85M118.82M143.16M130.21M69.41M
Enterprise Value
74.50M114.89M96.61M143.69M141.50M81.74M
Trailing P/E
14.1119.7855.33N/AN/AN/A
Forward P/E
N/A22.27N/AN/AN/AN/A
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
1.602.061.592.502.141.35
Price/Book (mrq)
2.763.403.11142.03N/AN/A
Enterprise Value/Revenue
1.1410.969.344.1014.769.49
Enterprise Value/EBITDA
5.76-21.52-101.276.76-70.50-35.77

Trading Information

Stock Price History

Beta (5Y Monthly) 0.91
52-Week Change 3-36.50%
S&P500 52-Week Change 328.64%
52 Week High 33.5500
52 Week Low 31.2100
50-Day Moving Average 31.5108
200-Day Moving Average 31.6951

Share Statistics

Avg Vol (3 month) 3325.08k
Avg Vol (10 day) 3479.51k
Shares Outstanding 573.05M
Implied Shares Outstanding 672.95M
Float 864.75M
% Held by Insiders 19.77%
% Held by Institutions 114.05%
Shares Short (Feb 29, 2024) 46.44M
Short Ratio (Feb 29, 2024) 422.02
Short % of Float (Feb 29, 2024) 49.06%
Short % of Shares Outstanding (Feb 29, 2024) 48.82%
Shares Short (prior month Jan 31, 2024) 45.84M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Dec 20, 2019
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Dec 20, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 12.69%
Operating Margin (ttm)-53.55%

Management Effectiveness

Return on Assets (ttm)9.32%
Return on Equity (ttm)72.50%

Income Statement

Revenue (ttm)65.49M
Revenue Per Share (ttm)0.97
Quarterly Revenue Growth (yoy)21.70%
Gross Profit (ttm)N/A
EBITDA 11.65M
Net Income Avi to Common (ttm)8.31M
Diluted EPS (ttm)0.0900
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)44.56M
Total Cash Per Share (mrq)0.61
Total Debt (mrq)26.28M
Total Debt/Equity (mrq)78.29%
Current Ratio (mrq)1.54
Book Value Per Share (mrq)0.46

Cash Flow Statement

Operating Cash Flow (ttm)-1.32M
Levered Free Cash Flow (ttm)-1.81M